LEF1 and COVID-19: This supports an independent predictive value of LEF1-AS1 and suggests that participants with lower baseline levels of LEF1-AS1 in their blood at the time of infection were more likely to experience post-COVID-19 cardiovascular and neurological complications (OR [95 % CI] 0.482 [0.280–0.830]).